Current concepts in multiple sclerosis : proceedings of the 6th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Tübingen, 11-13 October 1990
著者
書誌事項
Current concepts in multiple sclerosis : proceedings of the 6th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Tübingen, 11-13 October 1990
(International congress series, 960)
Excerpta Medica, 1991
大学図書館所蔵 全6件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes index
Sole distributors for the USA and Canada, Elsevier Science Pub. Co.
内容説明・目次
内容説明
In these proceedings of the 6th Congress of the European Committee for Treatment and Research in Multiple Sclerosis three main aspects of the disease are presented and discussed. Early diagnosis: Growing experience in early diagnostic methods raises several problems. When and to what extent should investigations be performed? And should the diagnostic results be revealed to the patient in full detail? Symptomatic treatment: Despite the scarcity of new developments many hospitals neglect the principles of symptomatic treatment or consider them as less important. A review of the basic symptomatic therapy is given. New developments: Therapies under examination (Corticosteroids, Azathioprine and Cyclophosphamide) or experimental therapies (Mitoxantrone) are described and discussed. Vaccination with T-cell receptor epitopes are presented in animals and human experimental settings. The congress contributions reflect research activities in all the major fields of MS. The book is also of considerable interest for neurologists and physicians actively involved in the treatment of MS patients.
目次
Welcome address. DIAGNOSIS. Ethics. (2 papers, 2 contributors) Methods. a. MRI (5 papers, 21 con.) b. Spectrometry (2 papers, 11 con.) c. PET (1 paper, 12 con.) d. Neurophysiology (7 papers, 30 con.) e. CSF and serum (13 papers, 53 con.) f. HLA (2 papers, 11 con.) Optic neuritis (2 papers, 12 con.) Neuropsychology (5 papers, 15 con.) SYMPTOMATIC TREATMENT. Ataxia and tremor (2 papers, 2 con.) Spasticity and pain (3 papers, 5 con.) Urinary tract (2 papers, 7 con.) NEW DEVELOPMETS. Therapies under examination. a. Steroids (6 papers, 23 con.) b. Azathioprine/Cyclosporine (2 papers, 9 con.) Experimental therapies. a. Mitoxanthrone (3 papers, 14 con.) b. Sulfosalazine (1 paper, 4 con.) c. Mab (1 paper, 7 con.) d. Irradiation (1 paper, 10 con.) Basic Research (7 papers, 42 con.) Experimental animal research (10 papers, 42 con.) MISCELLANEOUS. (3 papers, 9 con.) Index of authors.
「Nielsen BookData」 より